Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 213267
Company: NATCO
Company: NATCO
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| THALIDOMIDE | THALIDOMIDE | 150MG | CAPSULE;ORAL | Discontinued | None | No | No |
| THALIDOMIDE | THALIDOMIDE | 100MG | CAPSULE; ORAL | Prescription | None | No | No |
| THALIDOMIDE | THALIDOMIDE | 150MG | CAPSULE; ORAL | Prescription | None | No | No |
| THALIDOMIDE | THALIDOMIDE | 200MG | CAPSULE; ORAL | Prescription | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 04/27/2023 | ORIG-2 | Tentative Approval | STANDARD |
Label is not available on this site. |
|||
| 04/27/2023 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/213267Orig1s000ltr.pdf |